Interest rate pretzels and the Zoom shock on real estate
If long-term US interest rates stay below 2%, that’s a great sign for equity investors. But if they don’t…it’s amazing to see the pretzels that people contort into to convince themselves that rising rates are not a problem for equities. Also: an early look at the Zoom shock on commercial and residential real estate, and the diverging COVID trends in the US vs Europe.
ANNOUNCER:
This podcast has been prepared exclusively for institutional, wholesale, professional clients, and qualified investors only as defined by local laws and regulations. Please read other important information which can be found on the link at the end of the podcast episode.
[Music]
MR. MICHAEL CEMBALEST:
Good evening everybody and welcome to the March 2021 Eye on the Market podcast. There are three topics I want to be discussing today: interest rates and equities, the Zoom shock on commercial and residential real estate and a COVID update.
Also please join us on Thursday, this Thursday, we're going to have a webcast to discuss our SPAC research and the returns for all the different categories of investors.
So on the rate issue, if interest rates stay at or below 2% I think that's a great sign for equity investors and everybody would probably agree. Where there's disagreement is if interest rates don’t stay below 2% it's amazing to see the pretzels that people contort themselves into to convince themselves that rising rates aren't a problem for equities.
There's a ton of rationalizations that we walk through each with its own picture of a little pretzel in today's Eye on the Market. And it's amazing because this whole drumbeat of if rates rise, don't worry about equities from all the research people, I see it's kind of a cause for concern 'cause nobody wants to confront the possibility that there's a disconnect between Fed policy and the long bond and equity valuations.
We thought this year we'd get 10% returns or so on U.S. Large Cap stocks, assuming a big surge in consumer and business activity, widespread vaccinations, minimal disruption from vaccine resistant variants, another $2 trillion in fiscal stimulus for COVID and an infrastructure oriented bill in the fall, only part of which is offset by increased taxes on wealthy individuals and companies, a collapse in unemployment to around 4.5% by the end of the year, and then combining that with all sorts of investor euphoria as sky high valuations for everything growth related, things like that and small increases in interest rates and inflation.
So if rates stay at or below 2%, you know that view or that 10% return view is still in place. If rates hit 2.5% or higher, I would be much less optimistic in contrast to almost all the other research I see where people are talking about the reasons why they wouldn't worry about the rising--the impact of rising interest rates on equities.
The primary concern I would have is over the last few years we've had a surge in the price that investors pay for growth stocks. And you can look at that by just looking at the PE multiples relative to revenue growth. They are as high or if not higher, that ratio, than we had in 2000. And this has coincided with a period of not just low interest rates but low expectations for future rate increases. And you can look at something called the Term Premium from the New York Fed to track that.
The Term Premium is finally increasing as now, all of a sudden, there is more uncertainty about future rates and inflation and so I think this extreme price that people are paying for growth is going to come down a bit and so that's a headwind in a rising rate environment that I think some people are overlooking. We'll see.
We'll know how it goes over the next few months. Our estimate is that vaccinations plus non-vaccinated COVID survivors, right, so in other words two different source of antibody protection, is headed to around 70% by late May, right when over $1 trillion of the new $1.9 trillion in stimulus hits the economy: direct checks, small business aid, state and local aid. That much stimulus could eliminate a big chunk of the spare capacity that's lying around. And so we've talked about this before and we have some charts here on the output gap and some of the things that Larry Sommers has been saying.
It's interesting because the Fed has been wrong about rising inflation over almost the whole last decade. They thought it was going to up and they were wrong. Now they've gotten religion and they're betting the house on red which is that any revival in inflation is temporary and they're not worried about it. So I'm not sure the long bond is going to agree with them for that long. And so we'll see.
Now in a rising rate environment, there are some sectors that are doing pretty well: financials, right, obviously, steeper yield curves help banks' net operating income. We're having a big global post-COVID recovery in industrial production which is helping industrials and basic materials. And then the energy sector is doing well which is in part a COVID recovery story.
But I think even bigger is the story about industry consolidation and renewed management focus on free cash flow. We made a bullish call on oil and gas in our energy paper last June around the lows in oil and gas stocks 'cause we thought that the sector's problems which for a decade you could see were related more to the shale supply shock and management decisions to ignore profitability.
If you actually look at the price, 2010 to 2019, there was negative free cash flow in the entire shale industry. And about 20 or 30 companies, almost none of them, had even a couple of years of positive free cash flow. That's now changing and that's what's been helping the stocks since last June. And we're sticking with this call. Our energy paper comes out, by the way, in mid-May this year where we'll talk about that and a bunch of other topics.
The bottom line is that, again, as long as rates stay at 2% or below everything should be fine but I'm less optimistic that a rising rate environment can coincide with decent returns on large cap stocks. We'll see.
Now. I want to take an early look at the Zoom shock on U.S. and residential commercial real estate. A year ago I wrote that the U.S. would be 70-80% back to normal in a year. So that year is now. So if you look at energy consumption, capacity utilization, industrial production, consumer spending, housing starts, capital goods shipments, all of these things have recovered by at least 70-80% if not having now exceeded 2019 levels.
The one thing that I don't think is going to normalize that quickly is the number of people working from home compared to pre-COVID levels. I'm simplifying here but the average employee in the U.S. would prefer to work from home half the week. There's a distribution of expectations and desires but the average white collar employee would like to work from home 2.5 days a week whereas employers are kind of anywhere between .5 and 1 day. So there's a big bid offer between what employees want and what employers want.
If the compromise ends up someplace in the middle there's going to be something of a Zoom shock for office owners. There's some really interesting research that's been done on this Zoom shock to commercial real estate. And it refers to the fact that people aren't switching jobs. They still spend the same amount of money, almost everything about their lives stay the same, they just work from home instead.
And the people who study this are now looking by geographical area at the Zoom shock and we showed one of the maps for Greater London and you can see the intensity of the employment domicile inflow and outflow that tends to take place. And again it's not people losing and gaining jobs, it's just where they do the jobs but obviously that has a huge impact on residential, commercial real estate valuations.
One of the charts in here shows the amazing correlation between an estimate of how many jobs can be done from home, by zip code, and what the residential property prices changes were from over the last year. This is one of the most linear fits of a regression I've ever seen.
In addition cities where a lot of jobs can be done from home tend to have larger declines in commercial real estate valuations 'cause those denser cities are subject to Zoom shocks as well. And we have to start thinking about this kind of thing because the implications not just for home prices but for office rents, valuations, sublet volumes, the solvency and ridership of public transit systems, municipalities in terms of bond risks, the tax base, and tax rates and a whole range of businesses tied to office utilization rates in urban centers.
We have an early look so far. We show 10 large cities and the office utilization rates. Now there are some places like New York and San Francisco and Chicago where office utilization rates are still only 15-20% and we know that 'cause we have data on key card and fob data of office employees.
But even in Dallas and Houston and Austin where public transit is almost nonexistent, I mean the Census Bureau tracks that kind of thing, and the percentage of workers who commute by public transport in Dallas, Austin, and Houston is less than 5%. And yet those office utilization rates are only around 35%.
So here we are in an environment where people in those places can commute and reduce their COVID risks and the office utilization rates are still only about a third. And so it suggest that this battle between employers and employees on work from home is still underway and today's piece just gets into some of the potential implications of that.
So let's finish up with some COVID discussion. The COVID statistics continue to improve in the U.S. The pace of vaccination has picked up a lot in the last couple of weeks. And we have a chart that looks at partial vaccinations, full vaccinations, it's in today's Eye on the Market and you can see this pace has picked up a lot. And again you know mid-May we could be looking at 50% vaccination plus 20% non-vaccinated survivors.
It's possible the U.S., and this is what we're on track, it's possible the U.S. will win the race against time here because if you vaccinate quickly enough, you can run ahead of these more contagious and more deadly new variants. This U.K. B-117 variant is only around 10% in the U.S. And the South African and Brazil variants are present here but at less than .5% of new infections.
So if the U.S. continues to vaccinate aggressively, we can win this race against time on these new variants. And you can see Continental Europe is not winning that race. They're losing that race and they're paying a price for the squabbles they had with Astra-Zeneca and Oxford and with not diversifying their vaccine purchases more broadly and for some of the issues that took place in terms of questioning the efficacy of the Astra-Zeneca vaccine.
The U.K. variant is now spreading more rapidly in France, Italy, and The Netherlands. More than 50% of new infections and vaccinations are still only around 5-8%. So Italy had to shut down again in preparation for Easter holidays whereas the U.K., the data continued to decline as vaccinations hit 35% which is many multiples higher. And even though that U.K. variant is all over the U.K. the vaccination rates are running ahead of it and you're still seeing declines in the U.K. in hospitalizations, mortality, and infection.
So this is really turning out to be a battle between vaccination and variants. The U.S. is in much better shape that Europe.
Brazil's COVID situation is worth noting. It accounts for all of the worsening in Latin America since of most of the other countries in the region are actually improving. There's this very creepy mortality spike in the Amazon in Manaus. That was a place where it was believed that the herd mentality, or sorry, herd immunity had already been reached and so it was surprised to see a huge surge in mortality in the Amazon over the last couple of months. It's now rolling over but has spread to Minas Gerais, Sao Paulo, and Rio and Bahia and some of the other larger states.
So Brazil is the worst combination where you have extremely low vaccination rates and rapidly spreading, dangerous variants. This gets to a very interesting discussion that I was reading about the other day where the WHO and other international aid organizations are lobbying the U.S. aggressively which may end the month of June with a surplus of unused vaccines, lobbying them to share those with certain emerging economies 'cause as long as large emerging nations like Brazil are having these kinds of problems it's going to be difficult for the world to get back to normal. So far the Biden Administration hasn't taken a firm position on what they're going to do here. And it'll be interesting to watch this play out if we end up with a huge vaccine divide between the developed and the emerging world.
So that's it for today's piece. Thank you for listening. Again, please join us on Thursday for our SPAC call. Bye.
ANNOUNCER:
Michael Cembalest, Eye on the Market, offers a unique perspective on the economy, current events, markets and investment portfolios and is a production of JPMorgan Asset and Wealth Management.
Michael Cembalest is the Chairman of Market and Investment Strategy for JPMorgan Asset Management and is one of our most renowned and provocative speakers. For more information, please subscribe to the Eye on the Market by contacting your JPMorgan representative.
If you'd like to hear more, please explore episodes on iTunes or on our website. This podcast is intended for informational purposes only and is a communication on behalf of JPMorgan Institutional Investments, Incorporated.
Views may not be suitable for all investors and are not intended as personal investment advice or as solicitation or recommendation. Outlooks and past performance are never guarantees of future results. This is not investment research.
[END RECORDING]
Share
Eye on the Market
Important Information
This report uses rigorous security protocols for selected data sourced from Chase credit and debit card transactions to ensure all information is kept confidential and secure. All selected data is highly aggregated and all unique identifiable information, including names, account numbers, addresses, dates of birth, and Social Security Numbers, is removed from the data before the report’s author receives it. The data in this report is not representative of Chase’s overall credit and debit cardholder population.
The views, opinions and estimates expressed herein constitute Michael Cembalest’s judgment based on current market conditions and are subject to change without notice. Information herein may differ from those expressed by other areas of J.P. Morgan. This information in no way constitutes J.P. Morgan Research and should not be treated as such.
The views contained herein are not to be taken as advice or a recommendation to buy or sell any investment in any jurisdiction, nor is it a commitment from J.P. Morgan or any of its subsidiaries to participate in any of the transactions mentioned herein. Any forecasts, figures, opinions or investment techniques and strategies set out are for information purposes only, based on certain assumptions and current market conditions and are subject to change without prior notice. All information presented herein is considered to be accurate at the time of production. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine, together with their own professional advisers, if any investment mentioned herein is believed to be suitable to their personal goals. Investors should ensure that they obtain all available relevant information before making any investment. It should be noted that investment involves risks, the value of investments and the income from them may fluctuate in accordance with market conditions and taxation agreements and investors may not get back the full amount invested. Both past performance and yields are not reliable indicators of current and future results.
Non-affiliated entities mentioned are for informational purposes only and should not be construed as an endorsement or sponsorship of J.P. Morgan Chase & Co. or its affiliates.
For J.P. Morgan Asset Management Clients:
J.P. Morgan Asset Management is the brand for the asset management business of JPMorgan Chase & Co. and its affiliates worldwide.
To the extent permitted by applicable law, we may record telephone calls and monitor electronic communications to comply with our legal and regulatory obligations and internal policies. Personal data will be collected, stored and processed by J.P. Morgan Asset Management in accordance with our privacy policies at https://am.jpmorgan.com/global/privacy.
ACCESSIBILITY
For U.S. only: If you are a person with a disability and need additional support in viewing the material, please call us at 1-800-343-1113 for assistance.
This communication is issued by the following entities:
In the United States, by J.P. Morgan Investment Management Inc. or J.P. Morgan Alternative Asset Management, Inc., both regulated by the Securities and Exchange Commission; in Latin America, for intended recipients’ use only, by local J.P. Morgan entities, as the case may be.; in Canada, for institutional clients’ use only, by JPMorgan Asset Management (Canada) Inc., which is a registered Portfolio Manager and Exempt Market Dealer in all Canadian provinces and territories except the Yukon and is also registered as an Investment Fund Manager in British Columbia, Ontario, Quebec and Newfoundland and Labrador. In the United Kingdom, by JPMorgan Asset Management (UK) Limited, which is authorized and regulated by the Financial Conduct Authority; in other European jurisdictions, by JPMorgan Asset Management (Europe) S.à r.l. In Asia Pacific (“APAC”), by the following issuing entities and in the respective jurisdictions in which they are primarily regulated: JPMorgan Asset Management (Asia Pacific) Limited, or JPMorgan Funds (Asia) Limited, or JPMorgan Asset Management Real Assets (Asia) Limited, each of which is regulated by the Securities and Futures Commission of Hong Kong; JPMorgan Asset Management (Singapore) Limited (Co. Reg. No. 197601586K), which this advertisement or publication has not been reviewed by the Monetary Authority of Singapore; JPMorgan Asset Management (Taiwan) Limited; JPMorgan Asset Management (Japan) Limited, which is a member of the Investment Trusts Association, Japan, the Japan Investment Advisers Association, Type II Financial Instruments Firms Association and the Japan Securities Dealers Association and is regulated by the Financial Services Agency (registration number “Kanto Local Finance Bureau (Financial Instruments Firm) No. 330”); in Australia, to wholesale clients only as defined in section 761A and 761G of the Corporations Act 2001 (Commonwealth), by JPMorgan Asset Management (Australia) Limited (ABN 55143832080) (AFSL 376919). For all other markets in APAC, to intended recipients only.
For J.P. Morgan Private Bank Clients:
ACCESSIBILITY
J.P. Morgan is committed to making our products and services accessible to meet the financial services needs of all our clients. Please direct any accessibility issues to the Private Bank Client Service Center at 1-866-265-1727.
LEGAL ENTITY, BRAND & REGULATORY INFORMATION
In the United States, bank deposit accounts and related services, such as checking, savings and bank lending, are offered by JPMorgan Chase Bank, N.A. Member FDIC.
JPMorgan Chase Bank, N.A. and its affiliates (collectively “JPMCB”) offer investment products, which may include bank-managed investment accounts and custody, as part of its trust and fiduciary services. Other investment products and services, such as brokerage and advisory accounts, are offered through J.P. Morgan Securities LLC (“JPMS”), a member of FINRA and SIPC. Annuities are made available through Chase Insurance Agency, Inc. (CIA), a licensed insurance agency, doing business as Chase Insurance Agency Services, Inc. in Florida. JPMCB, JPMS and CIA are affiliated companies under the common control of JPM. Products not available in all states.
In Luxembourg, this material is issued by J.P. Morgan Bank Luxembourg S.A. (JPMBL), with registered office at European Bank and Business Centre, 6 route de Treves, L-2633, Senningerberg, Luxembourg. R.C.S Luxembourg B10.958. Authorized and regulated by Commission de Surveillance du Secteur Financier (CSSF) and jointly supervised by the European Central Bank (ECB) and the CSSF. J.P. Morgan Bank Luxembourg S.A. is authorized as a credit institution in accordance with the Law of 5th April 1993. In the United Kingdom, this material is issued by J.P. Morgan Bank Luxembourg S.A., London Branch, registered office at 25 Bank Street, Canary Wharf, London E14 5JP. Authorised and regulated by Commission de Surveillance du Secteur Financier (CSSF) and jointly supervised by the European Central Bank (ECB) and the CSSF. Deemed authorised by the Prudential Regulation Authority. Subject to regulation by the Financial Conduct Authority and limited regulation by the Prudential Regulation Authority. Details of the Temporary Permissions Regime, which allows EEA-based firms to operate in the UK for a limited period while seeking full authorisation, are available on the Financial Conduct Authority’s website. In Spain, this material is distributed by J.P. Morgan Bank Luxembourg S.A., Sucursal en España, with registered office at Paseo de la Castellana, 31, 28046 Madrid, Spain. J.P. Morgan Bank Luxembourg S.A., Sucursal en España is registered under number 1516 within the administrative registry of the Bank of Spain and supervised by the Spanish Securities Market Commission (CNMV). In Germany, this material is distributed by J.P. Morgan Bank Luxembourg S.A., Frankfurt Branch, registered office at Taunustor 1 (TaunusTurm), 60310 Frankfurt, Germany, jointly supervised by the Commission de Surveillance du Secteur Financier (CSSF) and the European Central Bank (ECB), and in certain areas also supervised by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin). In Italy, this material is distributed by J.P. Morgan Bank Luxembourg S.A– Milan Branch, registered office at Via Cordusio 3, 20123 Milano, Italy and regulated by Bank of Italy and the Commissione Nazionale per le Società e la Borsa (CONSOB). In the Netherlands, this material is distributed by J.P. Morgan Bank Luxembourg S.A., Amsterdam Branch, with registered office at World Trade Centre, Tower B, Strawinskylaan 1135, 1077 XX, Amsterdam, The Netherlands. J.P. Morgan Bank Luxembourg S.A., Amsterdam Branch is authorized and regulated by the Commission de Surveillance du Secteur Financier (CSSF) and jointly supervised by the European Central Bank (ECB) and the CSSF in Luxembourg; J.P. Morgan Bank Luxembourg S.A., Amsterdam Branch is also authorized and supervised by De Nederlandsche Bank (DNB) and the Autoriteit Financiële Markten (AFM) in the Netherlands. Registered with the Kamer van Koophandel as a branch of J.P. Morgan Bank Luxembourg S.A. under registration number 71651845. In Denmark, this material is distributed by J.P. Morgan Bank Luxembourg, Copenhagen Br, filial af J.P. Morgan Bank Luxembourg S.A. with registered office at Kalvebod Brygge 39-41, 1560 København V, Denmark. J.P. Morgan Bank Luxembourg, Copenhagen Br, filial af J.P. Morgan Bank Luxembourg S.A. is authorized and regulated by Commission de Surveillance du Secteur Financier (CSSF) and jointly supervised by the European Central Bank (ECB) and the CSSF. J.P. Morgan Bank Luxembourg, Copenhagen Br, filial af J.P. Morgan Bank Luxembourg S.A. is also subject to the supervision of Finanstilsynet (Danish FSA) and registered with Finanstilsynet as a branch of J.P. Morgan Bank Luxembourg S.A. under code 29009. In Sweden, this material is distributed by J.P. Morgan Bank Luxembourg S.A., Stockholm Bankfilial, with registered office at Hamngatan 15, Stockholm, 11147, Sweden. J.P. Morgan Bank Luxembourg S.A., Stockholm Bankfilial is authorized and regulated by Commission de Surveillance du Secteur Financier (CSSF) and jointly supervised by the European Central Bank (ECB) and the CSSF. J.P. Morgan Bank Luxembourg S.A., Stockholm Bankfilial is also subject to the supervision of Finansinspektionen (Swedish FSA). Registered with Finansinspektionen as a branch of J.P. Morgan Bank Luxembourg S.A. In France, this material is distributed by JPMorgan Chase Bank, N.A. (“JPMCB”), Paris branch, which is regulated by the French banking authorities Autorité de Contrôle Prudentiel et de Résolution and Autorité des Marchés Financiers. In Switzerland, this material is distributed by J.P. Morgan (Suisse) SA, which is regulated in Switzerland by the Swiss Financial Market Supervisory Authority (FINMA).
In Hong Kong, this material is distributed by JPMCB, Hong Kong branch. JPMCB, Hong Kong branch is regulated by the Hong Kong Monetary Authority and the Securities and Futures Commission of Hong Kong. In Hong Kong, we will cease to use your personal data for our marketing purposes without charge if you so request. In Singapore, this material is distributed by JPMCB, Singapore branch. JPMCB, Singapore branch is regulated by the Monetary Authority of Singapore. Dealing and advisory services and discretionary investment management services are provided to you by JPMCB, Hong Kong/Singapore branch (as notified to you). Banking and custody services are provided to you by JPMCB Singapore Branch. The contents of this document have not been reviewed by any regulatory authority in Hong Kong, Singapore or any other jurisdictions. You are advised to exercise caution in relation to this document. If you are in any doubt about any of the contents of this document, you should obtain independent professional advice. For materials which constitute product advertisement under the Securities and Futures Act and the Financial Advisers Act, this advertisement has not been reviewed by the Monetary Authority of Singapore. JPMorgan Chase Bank, N.A. is a national banking association chartered under the laws of the United States, and as a body corporate, its shareholder’s liability is limited.
With respect to countries in Latin America, the distribution of this material may be restricted in certain jurisdictions. We may offer and/or sell to you securities or other financial instruments which may not be registered under, and are not the subject of a public offering under, the securities or other financial regulatory laws of your home country. Such securities or instruments are offered and/or sold to you on a private basis only. Any communication by us to you regarding such securities or instruments, including without limitation the delivery of a prospectus, term sheet or other offering document, is not intended by us as an offer to sell or a solicitation of an offer to buy any securities or instruments in any jurisdiction in which such an offer or a solicitation is unlawful. Furthermore, such securities or instruments may be subject to certain regulatory and/or contractual restrictions on subsequent transfer by you, and you are solely responsible for ascertaining and complying with such restrictions. To the extent this content makes reference to a fund, the Fund may not be publicly offered in any Latin American country, without previous registration of such fund’s securities in compliance with the laws of the corresponding jurisdiction. Public offering of any security, including the shares of the Fund, without previous registration at Brazilian Securities and Exchange Commission— CVM is completely prohibited. Some products or services contained in the materials might not be currently provided by the Brazilian and Mexican platforms.
JPMorgan Chase Bank, N.A. (JPMCBNA) (ABN 43 074 112 011/AFS Licence No: 238367) is regulated by the Australian Securities and Investment Commission and the Australian Prudential Regulation
Authority. Material provided by JPMCBNA in Australia is to “wholesale clients” only. For the purposes of this paragraph the term “wholesale client” has the meaning given in section 761G of the Corporations Act 2001 (Cth). Please inform us if you are not a Wholesale Client now or if you cease to be a Wholesale Client at any time in the future.
JPMorgan Chase Bank, N.A. (JPMCBNA) (ABN 43 074 112 011/AFS Licence No: 238367) is regulated by the Australian Securities and Investment Commission and the Australian Prudential Regulation Authority. Material provided by JPMCBNA in Australia is to “wholesale clients” only. For the purposes of this paragraph the term “wholesale client” has the meaning given in section 761G of the Corporations Act 2001 (Cth). Please inform us if you are not a Wholesale Client now or if you cease to be a Wholesale Client at any time in the future.
JPMS is a registered foreign company (overseas) (ARBN 109293610) incorporated in Delaware, U.S.A. Under Australian financial services licensing requirements, carrying on a financial services business in Australia requires a financial service provider, such as J.P. Morgan Securities LLC (JPMS), to hold an Australian Financial Services Licence (AFSL), unless an exemption applies. JPMS is exempt from the requirement to hold an AFSL under the Corporations Act 2001 (Cth) (Act) in respect of financial services it provides to you, and is regulated by the SEC, FINRA and CFTC under U.S. laws, which differ from Australian laws. Material provided by JPMS in Australia is to “wholesale clients” only. The information provided in this material is not intended to be, and must not be, distributed or passed on, directly or indirectly, to any other class of persons in Australia. For the purposes of this paragraph the term “wholesale client” has the meaning given in section 761G of the Act. Please inform us immediately if you are not a Wholesale Client now or if you cease to be a Wholesale Client at any time in the future.
This material has not been prepared specifically for Australian investors. It:
- May contain references to dollar amounts which are not Australian dollars;
- May contain financial information which is not prepared in accordance with Australian law or practices;
- May not address risks associated with investment in foreign currency denominated investments; and
Does not address Australian tax issues.
© 2023 JPMorgan Chase & Co. All rights reserved.